摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

| 956354-23-7

中文名称
——
中文别名
——
英文名称
——
英文别名
——
化学式
CAS
956354-23-7
化学式
C18H24FN3O2S
mdl
——
分子量
365.472
InChiKey
PFESUJYRMWYELE-CTYIDZIISA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.28
  • 重原子数:
    25.0
  • 可旋转键数:
    6.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    71.09
  • 氢给体数:
    2.0
  • 氢受体数:
    4.0

文献信息

  • AMINE-DERIVATIVES HAVING NPY Y5 RECEPTOR ANTAGONISTIC ACTIVITY AND THE USES THEREOF
    申请人:OKUNO Takayuki
    公开号:US20100273841A1
    公开(公告)日:2010-10-28
    This invention provides an anorectic or anti-obesity composition comprising a compound of the formula (I): formula (I): a pharmaceutically acceptable salt or solvate thereof, wherein R 1 is optionally substituted lower alkyl, Y is —S(O)n- wherein n is 1 or 2, or —CO—, R 2 is hydrogen or lower alkyl, R 7 is hydrogen or lower alkyl, X is lower alkylene, lower alkenylene, arylene, cycloalkylene or the like, and Z is lower alkyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl or the like.
    本发明提供了一种厌食剂或抗肥胖组合物,包括公式(I)的化合物: 公式(I): 其药用可接受的盐或溶剂化物, 其中 R1是可选地取代的低级烷基, Y是—S(O)n—,其中n是1或2,或者—CO—, R2是氢或低级烷基, R7是氢或低级烷基, X是低级亚烷基,低级亚烯基,芳基,环烷基或类似物, Z是低级烷基,可选地取代的碳环烷基,可选地取代的杂环烷基或类似物。
  • AMINE DERIVATIVE HAVING NPY Y5 RECEPTOR ANTAGONIST ACTIVITY AND USE THEREOF
    申请人:Shionogi&Co., Ltd.
    公开号:EP2221051A1
    公开(公告)日:2010-08-25
    This invention provides an anorectic or anti-obesity composition comprising a compound of the formula (I); a pharmaceutically acceptable salt or solvate thereof, wherein R1 is optionally substituted lower alkyl, Y is -S(O)n- wherein n is 1 or 2, or -CO-, R2 is hydrogen or lower alkyl, R7 is hydrogen or lower alkyl, X is lower alkylene, lower alkenylene, arylene, cycloalkylene or the like, and Z is lower alkyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl or the like.
    本发明提供了一种包含式(I)化合物的厌食或抗肥胖组合物; 其药学上可接受的盐或溶液、 其中 R1 是任选取代的低级烷基、 Y 是-S(O)n-,其中 n 是 1 或 2,或-CO-、 R2 是氢或低级烷基 R7 是氢或低级烷基 X 是低级烯烃、低级烯烃、芳烃、环烷烃或类似物,以及 Z 是低级烷基、任选取代的碳环烷基、任选取代的杂环烷基或类似物。
  • Amine Derivative Having NPY Y5 Receptor Antagonistic Activity
    申请人:Okuno Takayuki
    公开号:US20100063027A1
    公开(公告)日:2010-03-11
    This invention provides a compound of the formula (I): a pharmaceutically acceptable salt or solvate thereof, wherein R 1 is optionally substituted lower alkyl, Y is —S(O) n — wherein n is 1 or 2, or —CO—, R 2 is hydrogen or lower alkyl, R 7 is hydrogen or lower alkyl, X is lower alkylene, lower alkenylene, arylene, cycloalkylene or the like, and Z is lower alkyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl or the like.
  • AMINE DERIVATIVES HAVING NPY Y5 RECEPTOR ANTAGONISTIC ACTIVITY AND THE USES THEREOF
    申请人:OKUNO Takayuki
    公开号:US20100273842A1
    公开(公告)日:2010-10-28
    This invention provides an anorectic or anti-obesity composition comprising a compound of the formula (I): a pharmaceutically acceptable salt or solvate thereof, wherein R 1 is optionally substituted lower alkyl, Y is —S(O) n — wherein n is 1 or 2, or —CO—, R 2 is hydrogen or lower alkyl, R 7 is hydrogen or lower alkyl, X is lower alkylene, lower alkenylene, arylene, cycloalkylene or the like, and Z is lower alkyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl or the like.
  • AMINE DERIVATIVE HAVING NPY Y5 RECEPTOR ANTAGONISTIC ACTIVITY
    申请人:Okuno Takayuki
    公开号:US20100267945A1
    公开(公告)日:2010-10-21
    A compound of the formula (I): a pharmaceutically acceptable salt or solvate thereof, where R 1 is optionally substituted lower alkyl, Y is —S(O) 2 —, R 2 is hydrogen or optionally substituted lower alkyl, R 7 is hydrogen or optionally substituted lower alkyl, X is a group of the formula: where R 5 and R 6 are each independently hydrogen, a group of the formula: is optionally substituted cycloalkylene, p is 0, and q is 1 or 2, Z is optionally substituted carbocyclyl or optionally substituted heterocyclyl, and provided that a compound wherein Z is fused heterocyclyl consisting of three rings or optionally substituted pyrimidinyl is excluded.
查看更多

同类化合物

铁(2+)六氟磷酸盐-1,10-菲咯啉(1:2:3) 钼,四羰基(1,10-亚铁试剂(邻二氮杂菲)-kN1,kN10)-,(OC-6-22)- 钌(2+)高氯酸酯-1,10-亚铁试剂(邻二氮杂菲)(1:2:3) 邻菲罗啉 苯甲酸,4,4'-[2,8-二(1,1-二甲基乙基)-4,10-二氢芘[4,5-D:9,10-D']二咪唑-5,11-二酰基]双- 胶原脯氨酸羟化酶抑制剂-1 石杉碱乙 氯化-1,10-菲咯啉水合物 氯(甘氨酰酸基)(1,10-菲咯啉)铜(II) 新铜试剂 新亚铜灵盐酸 吡嗪并[2,3-f]的[1,10]菲咯啉 吡嗪并[2,3-f][1,10]菲罗啉-2,3-二甲腈 吡喃联氮基[1,2,3,4-lmn][1,10]菲并啉二正离子(8CI,9CI) 双(2-苯并[h]喹啉-C2,N')(乙酰丙酮)合铱(III) 双(2,2-二吡啶)-(5-氨基邻二氮杂菲)双(六氟磷酸)钌 双(1,10-菲罗啉)钯(II)双(六氟磷酸盐) 二苯基1,10-亚铁试剂(邻二氮杂菲)-4,7-二磺酸酯 二氯(1,10-菲咯啉)铜(II) 二氯(1,10-亚铁试剂)铂(II) 二氯(1,10-亚铁试剂)钯(II) 二吡啶并[3,2-a:2',3'-c]吩嗪 二(菲咯啉)(二吡啶并吩嗪)钌(II) 二(氰基)二(1,10-菲咯啉)-铁 二(1,10-菲咯啉)铜 三(1,10-菲咯啉)双(六氟磷酸盐)钴(II) 三(1,10-菲咯啉)三(六氟磷酸盐)钴(III) 三菲咯啉钴(III) 三氟甲基(1,10-菲咯啉)铜(I)[Trifluoromethylator®] 三-(1,10-菲咯啉)钌 三(苯甲酰丙酮酸根)单(邻二氮杂菲)铕(III) 三(二苯甲酰甲烷)单(5-氨基-1,10-菲罗啉)铕(III) 三(1,10-菲咯啉)硫酸铁 丁夫罗林 N-乙基-7,10-二氢-8-硝基-7-氧代-N-乙基-1,10-菲罗啉-3-甲酰胺 N-[4-(苯并[b][1,7]菲并啉-7-基氨基)-3-(甲基氨基)苯基]甲磺酰胺盐酸(1:1) B-1,10-菲罗啉-5-基硼酸 B-1,10-菲罗啉-2-基-硼酸 9-甲酰基-1,10-菲咯啉-2-羧酸 9-溴-1-甲基-1,10-菲咯啉-2-酮 9-氯-1-甲基-1,10-菲咯啉-2-酮 8,15-二去氢-17-甲基-石松定-1(18H)-酮 6-(2-碘苯基)亚氨基-1,10-菲咯啉-5-酮 6,7-二氢-5,8-二甲基二苯并(b,j)(1,10)菲咯啉 6,6'-二氰基-7,7'-二乙氧基-3,3'-(乙烷-1,2-二基)-5,5'-二苯基-2,2'-联-1,8-二氮杂萘 5-醛基-1,10-菲咯啉 5-羧基-1,10-菲罗啉 5-羟基-1,10-菲咯啉 5-硝基邻二氮杂菲-2,9-二羧酸一水合物 5-硝基-6氨基-1,10-邻菲罗啉